Search - tctmd.com

Displaying 201 - 220 of 415

Sort: Relevancy | Date

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

Presentation ARCH 2019

Catheter Based Therapies After Surgical Mitral Interventions

Presenter: Alan Zajarias

April 12, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

Manuscript

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

February 06, 2019

News Daily News

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Yael L. Maxwell

January 14, 2019

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Daily News

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

Todd Neale

October 09, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

Featured Case: Late Coronary Sinus Thrombosis After TAVR: An Unexpected and Deadly Event

Presenter: Jorge Cortes Lawrenz, Juan F. Granada, Oscar A. Mendiz, Carlos Cabrera Arroyo, Carlos D Calderas, Anibal A. Damonte, Nabeel Ismaeil

September 24, 2018

Presentation TCT 2018

Clinical Impact of Valve Thrombosis After TAVR

Presenter: Martina Kelly Speight

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Advertisement

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Catheter Based Therapies After Surgical Mitral Interventions

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Calcification and Thrombosis as Mediators of Bioprosthetic Valve Deterioration

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

TCTMD’s Top 10 Most Popular Stories for September 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Featured Case: Late Coronary Sinus Thrombosis After TAVR: An Unexpected and Deadly Event

Clinical Impact of Valve Thrombosis After TAVR

High Mortality but Durable Results With Valve-in-Valve TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content